Calquence 100 mg film-coated tablets, ACALABRUTINIB clinical trials

SAKK 38/19: Assessing a ctDNA and PET-oriented therapy in patients with DLBCL. A multicenter, open-label, phase II trial

This study is looking at a new treatment called Calquence for a type of blood cancer called large B-cell lymphoma. It aims to see how well Calquence stops the cancer from growing and if it helps patients achieve complete remission.